Multicenter collaborative research on psychiatric symptoms of hematopoietic cell transplantation -Longitudinal study on entry and exit from sterile room and long-term prognosis-

Observation study of psychiatric symptoms in patients admitted to sterile rooms with hematopoietic cell transplantation - Observation study (Longitudinal study)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047644

Enrollment

Registered

2022-05-15

Start date

2017-05-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematological cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients over 20 years old (2) Patients who have received sufficient explanation in participating in this research and obtained written consent at their own free will. (3) Patients planning the first hematopoietic stem cell transplant for hematopoietic cancer (less than 5 points in Hematopoietic Cell Transplantation-Comorbidity Index)

Exclusion criteria

Exclusion criteria: (1) Patients with consciousness disturbance or severe dementia (2) Patients who have difficulty in evaluating by questionnaire or interview because their physical symptoms are severe. (3) Patients with speech / hearing or visual impairment that affect understanding of the method in the evaluation (4) Patients with psychiatric disorders other than depression, such as schizophrenia (5) Others who are judged to be inappropriate by the principal investigator or the co-investigator

Design outcomes

Primary

Measure	Time frame
CESD (The Center for Epidemiology Studies Depression scale) was performed before entering the sterile room, during entering the room, at the time of leaving the room, and 3, 6 and 12 months after leaving the room.	—

Secondary

Measure	Time frame
- POMS2 (Profile of Mood States 2nd Edition) was performed before entering the sterile room, during entering the room, at the time of leaving the room, and 3, 6 and 12 months after leaving the room. - Before entering the sterile room, SCID (Structured Clinical Interview for DSM-4 AXIS I Disorders), INTERMED, and MAC (Mental Adjustment to Cancer) were performed. - GHQ30 (The General Health Questionnaire) was performed 3, 6 and 12 months after leaving the room. - MMSE (Mini Mental State Examination) was performed before entering the sterile room and 12 months after leaving the room.	—

Measure

Time frame

- POMS2 (Profile of Mood States 2nd Edition) was performed before entering the sterile room, during entering the room, at the time of leaving the room, and 3, 6 and 12 months after leaving the room. - Before entering the sterile room, SCID (Structured Clinical Interview for DSM-4 AXIS I Disorders), INTERMED, and MAC (Mental Adjustment to Cancer) were performed. - GHQ30 (The General Health Questionnaire) was performed 3, 6 and 12 months after leaving the room. - MMSE (Mini Mental State Examination) was performed before entering the sterile room and 12 months after leaving the room.

—

Countries

Japan

Contacts

Public ContactKenji Yamamoto

Tokai University School of Medicine, Department of Psychiatry

key@is.icc.u-tokai.ac.jp+81463931121

Outcome results